Ocular Melanoma is a family disease. It doesn't just affect one person - having this diagnosis, the fear of the unknown can affect everyone from immediate family, friends, and more. Learning how to support each other with varying needs and boundaries amidst your diagnosis is worth the listen to this unique patient panel, led by patient and therapist, Carol McColl.Carol McColl has worked as a licensed professional counselor for 16 years, specializing in trauma recovery. She is also the author...

Ocular Melanoma patients face a LOT in their diagnosis journey. Facing the fear of recurrence, the fear around scans, fear of dying - there's a lot to unpack. Join us to hear from Katie Wilson, a therapist and patient herself, who specifically studies resilience and the development of post traumatic growth.Katie Wilson is a therapist and an adult educator. She received her master’s degree in counseling Psychology from Gonzaga in 2003. She has worked as a mental health clinician for almost 20...

Ocular Melanoma is enough to justify extra support. Dr. Allison Dashow, a patient and psychologist, shares a summary of therapies patients may find supportive, emphasizing the skills that can be developed to reach a point of radical acceptance in your diagnosis.Dr. Allie Dashow is a clinical psychologist and has been seeing clients for psychotherapy and group therapy for the past 6 years. She specializes in the following therapy modalities: cognitive behavioral therapy, dialectical behavioral...

Ocular Melanoma is a beast of a diagnosis. Fellow cancer survivor and patient Eve Bogdanove shares strategies for coping with your diagnosis and making meaning throughout the journey. Eve N. Bogdanove has been a clinical social worker for 28 years. She is a psychodynamically trained with additional training in IFS, SE, EMDR, DBT and is a AASECT Certified Sex & Gender Therapist.  She has expertise in CPTSD and working with perpetrators who harm their intimate partners.   Our mini seminar...

Join A Cure in Sight, an ocular melanoma foundation, to bring you an Eye Believe Mini-Seminar, Eye on COOG, where we're joined by Dr. Harbour, Dr. Reichstein, Dr. Williams, and Dr. Correa to discuss the Collaborative Ocular Oncology Group, it's founding and history, the research this collaborative study has yielded, and where COOG hopes to take the ocular melanoma community in the future. Topics covered:History of the COOG studyCurrent Published Studies from COOG (COOG 1 and COOG 2)The Future...

Barbara from Fred Hutch will talk about empowering yourself in survivorship. Barb is currently working at Fred Hutch in the Dept of Oncology serving as the APP for the Survivorship program. As a Stage 3c melanoma patient in surveillance she hopes to support her patients not only as their provider but fellow survivor. Email [email protected] with questions. ANNOUNCEMENTS: 5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved!  November...

In this session, hear from various experts about what it takes to get a drug to market. The bottom line is that research simply does NOT equal a cure. Learn from some of the best in the uveal melanoma pharma world about the process of bringing a treatment or new drug to market. Experts include Dr. Katz, Chief Medical Officer at TriSalus Life Sciences; Dr. Wade from Aura Bioscienes, Lucinda Innes, a PHD research student investigating uveal melanoma, and research board member Kevin. Dr. Steven...

Tune in to hear a patient panel on "What to do when you’re just fed up and DONE with OM," moderated by Dr. Danielle Archer. Dr. Danielle Archer is a licensed mental health therapist and stage IV cancer patient. She utilizes her clinical experience and her cancer journey to help cancer patients manage their mental health before, during and after treatment. Dr. Archer also works with oncology professionals to understand the importance of incorporating mental health into their treatment plans....

Tune in to hear more about what is palliative care and how to choose between palliative care and hospice, and when to call each of them. Ted Dropcho, MD, is a Palliative Care physician practicing at Virginia Mason Medical Center in Seattle. He serves patients with serious illness and their families. He finds meaning in his work through focusing on patients’ priorities and values to help navigate their courses with serious illness. He and the other members of the palliative care team give...

The first speaker, Gary Barg, spoke on the role of caregiving in a cancer diagnosis.   A noted speaker, writer and publisher on caregiving issues since 1995, Gary Barg is Founder and Editor-In-Chief of the first national magazine for caregivers, Today’s Caregiver, as well the original online caregiver community, caregiver.com. Today’s Caregiver magazine and caregiver.com combine information, advice and reader’s stories with interviews with celebrity caregiver such as Leeza Gibbons, Rob Lowe,...

Our final session covers metastatic disease. First, you will hear from Dr. Hall about finding and treating metastases, then from Lucinda Innes about current and upcoming clinical trials, and finally you will hear from Dr. Brechbiel about family and patient coping with a mets diagnosis. Dr. Evan Hall is an oncologist at Fred Hutch who specializes in treating patients with skin and kidney cancers. His research focuses on ways to measure and improve quality of life for patients with cancer. Dr....

This session is brought to you courtesy of sponsorship by IDEAYA Biosciences. "IDEAYA is a precision medicine oncology company with deep research and development expertise in synthetic lethality. We are passionately pursuing the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA has a world-class team of leading scientists and advisors with extensive knowledge and expertise in cancer biology, small molecule drug discovery,...

Join A Cure in Sight to hear from Todd and Tawnya Cranmore, board certified ocularists who share about Prosthetics 101 - understanding how a prosthetic is made, how to care for it, etc. Todd Cranmore is a Licensed Ocularist in Washington State, a Board Certified Ocularist (BCO) and a Board Approved Diplomate Ocularist (BADO). Combining medicine, artistry and engineering, Todd creates an amazing replica of the natural eye. Along with his education in ocular prosthetics, he has earned a degree...

Share this with your newly diagnosed omies friends--A Cure in Sight is joined by Dr. Andrew Stacey, Dr. Binkley, and Dr. Nguyen to discuss ocular treatments and side effects.   A special thanks to Aura Biosciences for sponsoring this session. Their clinical trial is noted by Dr. Binkley in this session. At Aura, their mission is to develop a new class of oncology targeted therapies that deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which they...

Join A Cure in Sight event host Danet Peterson to hear from Dr. Chen and Dr. Bowen on radiation basics. Understanding how a plaque is made, how radiation treatment is determined, and everything that goes into treating melanoma in the eye.   Dr. Chen; I am a board-certified radiation oncologist who specializes in caring for patients with ocular melanoma, the most common type of eye tumor, and genitourinary cancers (GU), which affect the urinary tract and male reproductive system. My expertise...

First up today you'll hear from Dr. Dennis Stacey, the father of Dr. Andrew Stacey. He will talk about the biology of cancer. Then you'll hear more from Dr. Andrew Stacey on the Biology of Uveal Melanoma. Finally you will hear from Dr. Lucinda Innes about different melanomas, different immunities. Dennis Stacey PhD. As a cancer researcher, Dennis has witnessed the explosion of information related to the causes and treatments for cancer.   Since the 1980s his laboratory has focused on...

Join event host and fellow patient Danet Peterson to chat with a few other omies on how they have coped with their diagnosis. Patients on the panel include Carrie Younger-Howard and Linda Boran. Reach out to [email protected] if you have interest in being part of a panel discussion on the podcast or at a future event.   ANNOUNCEMENTS: 5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved!  November 11, Los Angeles...

Join Melody Burchett, founder and President of A Cure in Sight, with communications and events coordinator, Hanna Hulick to discuss the INSIGHT Registry. This is a unique rare disease patient registry. insight.iamrare.org The INSIGHT Registry is an online registry for patients with Ocular Melanoma (OM). It will be hosted by the National Organization for Rare Disorders (NORD); an independent non-profit patient advocacy organization dedicated to individuals with rare diseases and the...

An interactive presentation by fellow patient, Anne Osborn, who discusses the benefits of meditation on whole body health and in aiding patients in coping with ocular melanoma. Anne Osborn, Author of the book, Coping with Ocular Melanoma: A toolbox, grew up in the shadows of OM when her mother died of OM. Forty years later, she was diagnosed with OM, Class 2. She spent her career in human services and trained as a psychotherapist. Her passions outside of family and friends include travel,...

Welcome to this year's Eye Believe 2023 Survivorship Seminar recording series. A discussion on Integrative Medicine and Ocular Melanoma with Blake Langley. Dr. Blake Langley is a licensed naturopathic physician and acupuncturist studying the impact of acupuncture therapies on quality of life and clinical outcomes in patients receiving active treatment for various cancers. As a Staff Scientist at the Fred Hutchinson Cancer Center, Dr. Langley works administers acupuncture for multiple clinical...

Part 3 of 3 in a mini series recording the EYE ON RESEARCH SEMINARJoin A Cure in Sight to chat with first, Dr. Moser and Dr. McKean regarding all drugs of interest pertaining to uveal melanoma that were discussed or presented on at ASCO 2023 - you can find this list here, courtesy of the ACIS Research board member. Following their presentation, tune in to hear some interesting and novel research in uveal melanoma that Dr. Dalvin heard at ARVO 2023, including key research presented for...